Literature DB >> 2621515

Substance abuse treatment modalities in the age of HIV spectrum disease.

J A Nathan1, L D Karan.   

Abstract

AMSAODD's Third National Forum on AIDS and Chemical Dependency presented a session about the theory and practicality of combining pharmacologic and nonpharmacologic treatment modalities to maximize the social, psychological, and physical health of patients. Synthesizing methadone maintenance for opioid dependence with abstinence modalities for cocaine dependence and alcoholism was discussed. Chronic adequate methadone treatment allows normalization of neuroendocrine function, is associated with normal natural killer-cell activity, and has proven efficacious in retaining patients in chemical dependence treatment, and thus decreasing the risk for transmission of HIV infection. Individualization of treatment is then exemplified by four clinical vignettes that were discussed by a panel of experts.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2621515     DOI: 10.1080/02791072.1989.10472188

Source DB:  PubMed          Journal:  J Psychoactive Drugs        ISSN: 0279-1072


  5 in total

1.  [Not Available].

Authors:  K Kurz-Müller; M Zenz
Journal:  Schmerz       Date:  1992-03       Impact factor: 1.107

Review 2.  Primary care for AIDS and chemical dependence.

Authors:  L D Karan
Journal:  West J Med       Date:  1990-05

3.  Predictors of methadone treatment retention from a multi-site study: a survival analysis.

Authors:  Sharon M Kelly; Kevin E O'Grady; Shannon Gwin Mitchell; Barry S Brown; Robert P Schwartz
Journal:  Drug Alcohol Depend       Date:  2011-02-09       Impact factor: 4.492

Review 4.  Pharmacological pain control for human immunodeficiency virus-infected adults with a history of drug dependence.

Authors:  Sanjay Basu; R Douglas Bruce; Declan T Barry; Frederick L Altice
Journal:  J Subst Abuse Treat       Date:  2007-01-09

5.  Retention in methadone and buprenorphine treatment among African Americans.

Authors:  Jan Gryczynski; Shannon Gwin Mitchell; Jerome H Jaffe; Sharon M Kelly; C Patrick Myers; Kevin E O'Grady; Yngvild K Olsen; Robert P Schwartz
Journal:  J Subst Abuse Treat       Date:  2013-04-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.